Ethinylestradiol sulfate
![]() | |
Clinical data | |
---|---|
Other names | EE sulfate; 17α-Ethynylestradiol 3-sulfate |
Drug class | Estrogen; Estrogen ester |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H24O5S |
Molar mass | 376.47 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
Ethinylestradiol sulfate (EE sulfate), also known as 17α-ethynylestradiol 3-sulfate, is an estrogen ester – specifically, the C3 sulfuric acid (sulfate) ester of the synthetic estrogen ethinylestradiol (EE) – and is the major metabolite of EE.[1][2][3] Circulating levels of EE sulfate range from 6 to 22 times those of EE when EE is taken orally.[1][2][3] EE sulfate can be transformed back into EE (14–21%) via steroid sulfatase, and it has been suggested that EE sulfate may serve as a circulating reservoir for EE, similarly to the case of estrone sulfate with estradiol.[4][5][3][1] However, the EE sulfate pool with EE is far smaller than the pool of estrone sulfate that occurs with estradiol (with estrone sulfate levels approximately 200-fold higher than estradiol levels on average with oral estradiol).[1] In addition, in contrast to the case of estrone sulfate and estrone, the conversion rate of EE sulfate back into EE is relatively low, and has been said probably isn't of clinical significance.[5] However, other studies have suggested that EE sulfate may nonetheless contribute up to 20% of total EE levels.[2][6]
See also[]
- List of estrogen esters § Esters of other steroidal estrogens
References[]
- ^ a b c d Kuhl H (2005). "Pharmacology of estrogens and progestogens: influence of different routes of administration" (PDF). Climacteric. 8 Suppl 1: 3–63. doi:10.1080/13697130500148875. PMID 16112947. S2CID 24616324.
- ^ a b c Michael Oettel; Ekkehard Schillinger (6 December 2012). Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen. Springer Science & Business Media. pp. 284–285, 290. ISBN 978-3-642-60107-1.
- ^ a b c Fotherby K (August 1996). "Bioavailability of orally administered sex steroids used in oral contraception and hormone replacement therapy". Contraception. 54 (2): 59–69. doi:10.1016/0010-7824(96)00136-9. PMID 8842581.
- ^ Goldzieher JW, Mileikowsky G, Newburger J, Dorantes A, Stavchansky SA (1988). "Human pharmacokinetics of ethynyl estradiol 3-sulfate and 17-sulfate". Steroids. 51 (1–2): 63–79. doi:10.1016/0039-128x(88)90185-7. PMID 3242167. S2CID 21188869.
- ^ a b Donna Shoupe; Florence P. Haseltine (6 December 2012). Contraception. Springer Science & Business Media. pp. 19–. ISBN 978-1-4612-2730-4.
- ^ Mattison DR, Karyakina N, Goodman M, LaKind JS (September 2014). "Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps". Crit. Rev. Toxicol. 44 (8): 696–724. doi:10.3109/10408444.2014.930813. PMID 25099693. S2CID 11212469.
- Alkyne derivatives
- Tertiary alcohols
- Estranes
- Estrogen esters
- Human drug metabolites
- Prodrugs
- Sulfate esters
- Synthetic estrogens
- Steroid stubs
- Genito-urinary system drug stubs